Type II collagen peptide Coll2-1 is an actor of synovitis

Area of Science:

• Immunology
• Rheumatology
• Cell Biology

Background:

• Type II collagen is a major component of cartilage.
• Inflammatory pathways in synovial cells contribute to joint destruction in arthritis.
• The role of specific collagen peptides in arthritis pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the pro-inflammatory potential of Coll2-1 peptide in synovial cells.
• To determine if Coll2-1 peptide can induce arthritis in a Lewis rat model.
• To explore the therapeutic implications of targeting Coll2-1 in arthritis.

Main Methods:

• Human synoviocytes and chondrocytes were cultured with Coll2-1 peptide and inhibitors of TLR-4 signaling and reactive oxygen species (ROS).
• Interleukin-8 (IL-8), Vascular Endothelium Growth Factor (VEGF), IκB-α, and p65 phosphorylation were assessed.
• Arthritis was induced in Lewis rats by injecting Coll2-1 peptide, bovine type II collagen (CIA), or streptococcal cell wall (SCW), followed by histological assessment.

Main Results:

• Coll2-1 significantly increased IL-8 gene expression and production in synoviocytes, mediated partly by TLR-4 signaling and ROS.
• Coll2-1 induced phosphorylation of p65 and IκBα, indicating activation of the NF-κB pathway.
• Coll2-1 injection in Lewis rats triggered arthritis, characterized by synovitis, cartilage degradation, and bone remodeling, similar to CIA and SCW models.

Conclusions:

• Coll2-1 peptide activates pro-inflammatory pathways in synovial cells and induces arthritis in rats.
• These findings highlight Coll2-1 as a potential therapeutic target for arthritis.
• Neutralizing Coll2-1 may represent a novel therapeutic strategy for inflammatory joint diseases.